![Ning Shan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ning Shan is currently the Chief Scientific Officer at Aclipse Therapeutics LLC.
Previously, he worked as the Director of Preclinical Development at Thar Pharmaceuticals, Inc. Dr. Shan holds a doctorate degree from the University of Cambridge and an undergraduate degree from Wuhan University.
| Companies | Position | Start |
|---|---|---|
Aclipse Therapeutics LLC
 Aclipse Therapeutics LLC Pharmaceuticals: GenericHealth Technology Develops drugs | Chief Tech/Sci/R&D Officer | - |
| Companies | Position | End |
|---|---|---|
Thar Pharmaceuticals, Inc.
 Thar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a specialty pharmaceutical company | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 4 |
|---|---|
Thar Pharmaceuticals, Inc.
Thar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a specialty pharmaceutical company | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wuhan University
 Wuhan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aclipse Therapeutics LLC
Aclipse Therapeutics LLC Pharmaceuticals: GenericHealth Technology Develops drugs | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
Choose MarketScreener 
